SYNH Syneos Health, Inc. Stock Quote

SYNH [NASD]

Healthcare | Diagnostics & Research | USA

Index	-	P/E	46.65	EPS (ttm)	1.83	Insider Own	0.40%	Shs Outstand	103.93M	Perf Week	7.68%
Market Cap	8.83B	Forward P/E	17.49	EPS next Y	4.87	Insider Trans	-99.46%	Shs Float	61.16M	Perf Month	11.76%
Income	192.80M	PEG	2.87	EPS next Q	0.74	Inst Own	95.89%	Short Float	8.93%	Perf Quarter	13.01%
Sales	4.42B	P/S	2.00	EPS this Y	46.20%	Inst Trans	0.79%	Short Ratio	5.63	Perf Half Y	40.23%
Book/sh	31.19	P/B	2.73	EPS next Y	14.93%	ROA	2.50%	Target Price	86.73	Perf Year	65.46%
Cash/sh	2.63	P/C	32.46	EPS next 5Y	16.23%	ROE	6.30%	52W Range	46.74 - 86.88	Perf YTD	25.10%
Dividend	-	P/FCF	23.53	EPS past 5Y	-1.20%	ROI	4.60%	52W High	-1.90%	Beta	1.85
Dividend %	-	Quick Ratio	1.10	Sales past 5Y	25.80%	Gross Margin	23.00%	52W Low	82.35%	ATR	2.42
Employees	24310	Current Ratio	1.10	Sales Q/Q	-6.00%	Oper. Margin	6.60%	RSI (14)	68.21	Volatility	3.13% 2.92%
Optionable	Yes	Debt/Eq	0.91	EPS Q/Q	0.90%	Profit Margin	4.40%	Rel Volume	1.12	Prev Close	86.25
Shortable	Yes	LT Debt/Eq	0.90	Earnings	Apr 29 BMO	Payout	0.00%	Avg Volume	969.09K	Price	85.23
Recom	1.80	SMA20	9.01%	SMA50	11.17%	SMA200	28.40%	Volume	1,137,228	Change	-1.18%

Mar-03-21

Initiated

Barclays

Equal Weight

$84

Oct-06-20

Upgrade

Mizuho

Neutral → Buy

$65

Oct-01-20

Upgrade

Goldman

Neutral → Buy

$69 → $75

Mar-30-20

Downgrade

Goldman

Buy → Neutral

$79 → $45

Jan-07-20

Initiated

Citigroup

Buy

$75

Oct-19-18

Upgrade

William Blair

Mkt Perform → Outperform

Oct-09-18

Initiated

UBS

Buy

Oct-04-18

Initiated

Evercore ISI

Outperform

$58

Apr-15-21 06:22AM	Here's Why I Think Syneos Health (NASDAQ:SYNH) Might Deserve Your Attention Today Simply Wall St. +7.86%
Apr-14-21 01:06PM	Is SYNH Stock A Buy or Sell? Insider Monkey
Apr-01-21 04:01PM	Syneos Health Schedules First Quarter 2021 Earnings Call for Thursday, April 29, 2021 GlobeNewswire
Mar-31-21 01:38PM	Reasons to Hold on to Syneos Health (SYNH) Stock For Now Zacks
Mar-30-21 11:44AM	Syneos Health (SYNH) New Partnership to Enhance Clinical Trials Zacks
Mar-29-21 07:00AM	Syneos Health Partners with Science 37® to Transform Clinical Trials Increasing Speed and Diversity GlobeNewswire
Mar-20-21 11:30AM	Why Is Syneos Health (SYNH) Up 4.1% Since Last Earnings Report? Zacks
Mar-16-21 07:18AM	What Does Syneos Health, Inc.'s (NASDAQ:SYNH) Share Price Indicate? Simply Wall St.
Mar-15-21 09:00AM	Syneos Health Communications Boosts Global Creative Capabilities with Renowned Talent GlobeNewswire
Mar-12-21 06:07PM	AnaptysBio and Seagate Technology See Activist Action Barrons.com
Mar-01-21 09:28AM	Syneos Health Announces Pricing of Secondary Offering of Common Stock GlobeNewswire
06:44AM	Syneos Health Announces Secondary Offering of Common Stock GlobeNewswire
Feb-24-21 09:00AM	Syneos Health and Protocol First Partner to Accelerate Collection and Review of Clinical Trial Data GlobeNewswire +5.06%
Feb-19-21 02:18PM	Price Over Earnings Overview: Syneos Health Benzinga
Feb-18-21 02:00PM	Syneos Health, Inc. (SYNH) Q4 2020 Earnings Call Transcript Motley Fool
07:54AM	Syneos Health: Q4 Earnings Insights Benzinga
06:53AM	Did You Miss Syneos Health's (NASDAQ:SYNH) Impressive 107% Share Price Gain? Simply Wall St.
06:15AM	Syneos Health Reports Fourth Quarter and Full Year 2020 Results GlobeNewswire
Feb-11-21 08:00AM	Syneos Health Identifies Important Drivers of Change Expected to Disrupt Healthcare GlobeNewswire
Jan-26-21 06:37PM	Syneos Health Schedules Fourth Quarter and Full Year 2020 Earnings Call for Thursday, February 18, 2021 GlobeNewswire
Jan-13-21 04:23AM	Have Insiders Been Buying Syneos Health, Inc. (NASDAQ:SYNH) Shares? Simply Wall St.
Jan-07-21 07:30AM	Why It Might Be Time To Pay Attention To These 3 Red-Hot Health Stocks Investor's Business Daily
07:15AM	Are These Medical Stocks Cruising Toward Bullish Gains? Here's A Key Sign Investor's Business Daily
Jan-04-21 04:15PM	Syneos Health to Present at the 39th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Dec-21-20 08:48AM	Syneos Health (SYNH) Buys Illingworth Research, Expands CRO Base Zacks
Dec-18-20 09:14AM	Syneos Health Acquires Illingworth Research Group, a Leading Provider of Clinical Research Home Health Services GlobeNewswire
04:00AM	Syneos Health, Inc.'s (NASDAQ:SYNH) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects? Simply Wall St.
Dec-16-20 08:08AM	Syneos Health's (SYNH) Shares March Higher, Can It Continue? Zacks
Dec-15-20 10:28AM	Is SYNH A Good Stock To Buy Now? Insider Monkey
Dec-14-20 10:37AM	Billionaire David Shaw Bets Big on These 3 Healthcare Stocks TipRanks
Dec-11-20 09:30AM	Is Syneos Health (SYNH) a Good Value Investor Stock Now? Zacks
Dec-10-20 08:59AM	Syneos Health Completes Acquisition of Synteract GlobeNewswire
Dec-07-20 05:18PM	Syneos Health to Outline Value Creation Plan at 2020 Analyst and Investor Event GlobeNewswire
08:00AM	VBI Vaccines Selects Syneos Health as Commercialization Partner for Prophylactic 3-Antigen Hepatitis B Vaccine Business Wire
Dec-03-20 08:49AM	Syneos Health and ConcertAI Announce Strategic Collaboration to Accelerate the Use of Real World Evidence and AI to Advance Oncology Research GlobeNewswire
Dec-02-20 08:30AM	Syneos Health Announces Pricing of Secondary Offering of Common Stock GlobeNewswire
Dec-01-20 04:21PM	Syneos Health Announces Secondary Offering of Common Stock GlobeNewswire
Nov-30-20 11:42AM	Here's Why You Should Invest in Syneos Health (SYNH) Now Zacks
Nov-25-20 03:36AM	Estimating The Fair Value Of Syneos Health, Inc. (NASDAQ:SYNH) Simply Wall St.
Nov-24-20 06:07PM	Syneos Health Announces Closing of Offering of $600.0 Million of Senior Notes Due 2029 GlobeNewswire
Nov-18-20 06:52PM	Syneos Health Announces Upsizing and Pricing of Offering of $600.0 Million of Senior Notes Due 2029 GlobeNewswire
07:22AM	Syneos Health Announces Senior Notes Offering GlobeNewswire
Nov-17-20 08:40AM	Syneos Health Names Larry A. Pickett Jr. Chief Information & Digital Officer GlobeNewswire
Nov-16-20 08:43AM	Syneos Health to Host Virtual Analyst and Investor Event on December 8, 2020 GlobeNewswire
Nov-12-20 08:56AM	1Life Healthcare (ONEM) in Focus: Stock Moves 6.3% Higher Zacks
Nov-03-20 08:19AM	Syneos Health (SYNH) Q3 Earnings Top Estimates, Margins Up Zacks
Nov-02-20 05:20PM	Syneos Health to Present at Upcoming Investor Conferences GlobeNewswire +5.40%
10:43AM	Syneos Health, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For Next Year Simply Wall St.
Oct-30-20 01:08PM	If You Like EPS Growth Then Check Out Syneos Health (NASDAQ:SYNH) Before It's Too Late Simply Wall St.
Oct-29-20 07:59AM	Syneos Health: Q3 Earnings Insights Benzinga
07:35AM	Syneos Health (SYNH) Tops Q3 Earnings Estimates Zacks
06:13AM	Syneos Health Reports Third Quarter 2020 Results GlobeNewswire
06:00AM	Syneos Health, Inc. to Host Earnings Call ACCESSWIRE
Oct-28-20 05:39PM	Syneos Health to Acquire Synteract, a Top CRO Provider to Emerging Biopharma GlobeNewswire
Oct-22-20 12:33PM	Syneos Health (SYNH) Reports Next Week: Wall Street Expects Earnings Growth Zacks
Oct-21-20 06:30AM	Syneos Health® Launches Kinetic Omnichannel Capability to Accelerate Modern Customer Engagement GlobeNewswire
Oct-19-20 06:30AM	Syneos Health Named to Forbes 2020 List of Worlds Best Employers GlobeNewswire
Oct-13-20 08:45AM	Syneos Health Wins Society for Clinical Research Sites Eagle Award for Fourth Consecutive Year GlobeNewswire
Oct-07-20 11:45AM	Is Syneos Health, Inc. (NASDAQ:SYNH) Potentially Undervalued? Simply Wall St.
Oct-05-20 04:58PM	Syneos Health Schedules Third Quarter 2020 Earnings Call for Thursday, October 29, 2020 GlobeNewswire
Sep-28-20 09:59AM	Syneos Health Banks on Essential Therapies Amid Coronavirus Woe Zacks
Sep-16-20 06:20PM	Analyst Report: Syneos Health, Inc. Morningstar Research -10.23%
04:52PM	Hedge Funds Have Never Been This Bullish On Syneos Health, Inc. (SYNH) Insider Monkey
08:52AM	Syneos Health Announces Pricing of Secondary Offering of Common Stock GlobeNewswire
Sep-15-20 04:51PM	Syneos Health Announces Secondary Offering of Common Stock GlobeNewswire
Sep-10-20 02:42PM	If You Had Bought Syneos Health (NASDAQ:SYNH) Shares Five Years Ago You'd Have Earned25% Returns Simply Wall St.
Sep-09-20 10:55AM	Update: Syneos Health to Present at the Baird 2020 Global Healthcare Conference at 12:15 p.m. ET Today GlobeNewswire
Sep-05-20 11:32AM	Syneos Health (SYNH) Down 8.2% Since Last Earnings Report: Can It Rebound? Zacks
Sep-02-20 07:30AM	Syneos Health to Present at the Baird 2020 Global Healthcare Conference GlobeNewswire
Sep-01-20 08:12AM	Syneos Health-Idorsia Collaborate to Launch Daridorexant in US Zacks
Aug-11-20 09:50AM	Syneos Health (SYNH) Q2 Earnings Top Estimates, Margins Down Zacks
Aug-06-20 09:45AM	Syneos Health (SYNH) Q2 Earnings and Revenues Surpass Estimates Zacks
06:14AM	Syneos Health Reports Second Quarter 2020 Results GlobeNewswire
Jul-30-20 12:33PM	Earnings Preview: Syneos Health (SYNH) Q2 Earnings Expected to Decline Zacks
Jul-20-20 11:02AM	Did Hedge Funds Make The Right Call On Syneos Health, Inc. (SYNH) ? Insider Monkey
Jul-13-20 08:30AM	Syneos Health Signs New Service Agreement With Pfizer GlobeNewswire
Jul-11-20 05:42PM	Notable Insider Buys: Acceleron, Continental And Syneos Health Benzinga
03:46PM	Top Insider Buys Highlight for the Week of July 10 GuruFocus.com
Jul-07-20 08:00AM	Syneos Health Bolsters Communications Leadership Team GlobeNewswire
Jul-01-20 03:37PM	Syneos Health Schedules Second Quarter 2020 Earnings Call for Thursday, August 6, 2020 GlobeNewswire
Jun-22-20 08:42AM	Invitae (NVTA) Looks Good: Stock Adds 5.8% in Session Zacks
Jun-19-20 09:38AM	Senseonics Holdings (SENS) Catches Eye: Stock Jumps 5.7% Zacks
Jun-17-20 01:52PM	Hedge Funds Are Nibbling On Syneos Health, Inc. (SYNH) Insider Monkey
11:08AM	Edited Transcript of SYNH.OQ earnings conference call or presentation 30-Apr-20 12:00pm GMT Thomson Reuters StreetEvents
Jun-16-20 08:43AM	Allscripts (MDRX) Looks Good: Stock Adds 9.1% in Session Zacks
08:39AM	10x Genomics (TXG) Looks Good: Stock Adds 6.2% in Session Zacks
May-30-20 11:31AM	Syneos Health (SYNH) Up 9.3% Since Last Earnings Report: Can It Continue? Zacks
May-28-20 08:30AM	Daiichi Sankyo and Syneos Health® Form Strategic Coalition for Development of Daiichi Sankyos ADC Oncology Pipeline Business Wire
May-22-20 08:39AM	Syneos Health to Present at Upcoming Investor Conferences GlobeNewswire
May-13-20 12:15PM	Syneos Health to Present at the UBS Virtual Global Healthcare Conference GlobeNewswire
May-04-20 10:26AM	Syneos Health (SYNH) Tops Q1 Earnings Estimates, Margins Down Zacks
Apr-30-20 06:00PM	Syneos Health, Inc. (SYNH) Q1 2020 Earnings Call Transcript Motley Fool
07:55AM	Syneos Health (SYNH) Beats Q1 Earnings and Revenue Estimates Zacks
06:34AM	Syneos Health Reports First Quarter 2020 Results GlobeNewswire
Apr-23-20 12:32PM	Syneos Health (SYNH) Reports Next Week: Wall Street Expects Earnings Growth Zacks
Apr-07-20 06:54AM	Syneos Health Provides COVID-19 Business Update GlobeNewswire
Apr-03-20 04:17PM	Syneos Health Responds to COVID-19 Public Health Challenge by Joining Call to Action to Activate Clinically-Qualified Healthcare Professionals GlobeNewswire
Apr-02-20 02:54PM	Gone: Triangle public companies lose $30 billion in value during 1Q 2020 American City Business Journals
Apr-01-20 02:31PM	Triangle firm shines light on alternative to ventilators in battle against COVID-19 American City Business Journals -8.22%
Mar-30-20 12:09PM	Syneos Health Launches Initiative for COVID-19 Patients Zacks

Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers various services spanning Phases I to IV of clinical development, including full service global studies, as well as individual service offerings, such as clinical monitoring, investigator recruitment, patient recruitment, data management, and study startup to assist customers with their drug development process. The Commercial Solutions segment provides commercialization services comprising deployment solutions; communications solutions, such as public relations, advertising, and medical communications; and consulting services. Its customers include small, mid-sized, and large companies in the pharmaceutical, biotechnology, and medical device industries. Syneos Health, Inc. has a partnership with VBI Vaccines Inc. for the commercialization of 3-antigen prophylactic hepatitis B vaccine in the United States, Europe, and Canada, which is in pending regulatory approvals. The company was formerly known as INC Research Holdings, Inc. and changed its name to Syneos Health, Inc. in January 2018. Syneos Health, Inc. was incorporated in 2010 and is headquartered in Morrisville, North Carolina

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Meggs Jason M.	Chief Financial Officer	Apr 15	Sale	84.00	6,000	504,000	60,701	Apr 16 05:18 PM
KEEFE MICHELLE	Pres., Commercial Solutions	Apr 15	Sale	82.00	2,736	224,352	43,895	Apr 16 05:16 PM
Macdonald Alistair	Chief Executive Officer	Apr 09	Sale	80.00	14,039	1,123,120	200,470	Apr 12 05:01 PM
Macdonald Alistair	Chief Executive Officer	Apr 01	Option Exercise	40.12	17,398	698,008	231,907	Apr 05 05:00 PM
Macdonald Alistair	Chief Executive Officer	Apr 01	Sale	77.61	17,398	1,350,190	214,509	Apr 05 05:00 PM
Olefson Jonathan	General Counsel & Corp Secty	Mar 29	Sale	77.00	4,000	308,000	24,725	Mar 31 05:08 PM
Harty Linda S	Director	Mar 29	Sale	76.49	7,310	559,142	6,925	Mar 31 05:06 PM
ADVENT INTERNATIONAL CORP/MA	10% Owner	Mar 03	Sale	74.17	4,654,046	345,213,862	10,764,749	Mar 05 07:12 PM
ADVENT INTERNATIONAL CORP/MA	10% Owner	Mar 03	Sale	74.17	4,654,046	345,213,862	10,764,749	Mar 05 07:02 PM
ADVENT INTERNATIONAL CORP/MA	10% Owner	Mar 03	Sale	74.17	4,654,046	345,213,862	10,764,749	Mar 05 06:53 PM
Maldonado John L.	Director	Mar 03	Sale	74.17	4,654,046	345,213,862	10,764,749	Mar 05 07:52 PM
Allen Tom	Director	Mar 03	Sale	74.17	4,654,046	345,213,862	10,764,749	Mar 05 07:44 PM
ADVENT INTERNATIONAL CORP/MA	10% Owner	Mar 03	Sale	74.17	4,654,046	345,213,862	10,764,749	Mar 05 07:37 PM
ADVENT INTERNATIONAL CORP/MA	10% Owner	Mar 03	Sale	74.17	4,654,046	345,213,862	10,764,749	Mar 05 07:29 PM
ADVENT INTERNATIONAL CORP/MA	10% Owner	Mar 03	Sale	74.17	4,654,046	345,213,862	10,764,749	Mar 05 07:22 PM
THOMAS H. LEE ADVISORS, LLC	Director	Mar 03	Sale	74.17	3,995,019	296,330,534	9,106,651	Mar 05 05:00 PM
THOMAS H. LEE ADVISORS, LLC	Director	Mar 03	Sale	74.17	935	69,354	572	Mar 05 05:00 PM
THOMAS H. LEE ADVISORS, LLC	Director	Mar 03	Sale	74.17	3,995,019	296,330,534	9,106,651	Mar 05 05:01 PM
THOMAS H. LEE ADVISORS, LLC	Director	Mar 03	Sale	74.17	935	69,354	572	Mar 05 05:01 PM
Kralowetz Donna Hildebrand	SVP, Chief Accounting Officer	Mar 03	Sale	74.64	248	18,511	5,959	Mar 04 05:23 PM
Macdonald Alistair	Chief Executive Officer	Mar 02	Option Exercise	0.00	36,429	0	231,631	Mar 04 05:44 PM
Kralowetz Donna Hildebrand	SVP, Chief Accounting Officer	Feb 16	Sale	81.00	362	29,322	5,959	Feb 18 05:04 PM
Macdonald Alistair	Chief Executive Officer	Feb 02	Sale	77.11	278	21,438	210,043	Feb 03 05:28 PM
Macdonald Alistair	Chief Executive Officer	Feb 01	Sale	75.71	64,219	4,861,809	210,321	Feb 03 05:28 PM
COLVIN PAUL	Pres., Clinical Solutions	Feb 01	Sale	74.82	8,486	634,923	28,275	Feb 03 05:15 PM
Olefson Jonathan	General Counsel & Corp Secty	Jan 25	Sale	75.68	5,336	403,828	27,214	Jan 27 05:13 PM
KEEFE MICHELLE	Pres., Commercial Solutions	Jan 25	Sale	75.68	4,000	302,720	52,051	Jan 27 05:09 PM
Meggs Jason M.	Chief Financial Officer	Jan 06	Sale	72.00	5,552	399,744	58,951	Jan 07 05:03 PM
Macdonald Alistair	Chief Executive Officer	Dec 23	Sale	70.52	300	21,155	245,187	Dec 28 05:07 PM
Macdonald Alistair	Chief Executive Officer	Dec 22	Sale	70.02	1,200	84,020	245,487	Dec 28 05:07 PM
ADVENT INTERNATIONAL CORP/MA	10% Owner	Dec 03	Sale	61.28	3,228,241	197,826,608	15,418,795	Dec 07 05:27 PM
Allen Tom	Director	Dec 03	Sale	61.28	3,228,241	197,826,608	15,418,795	Dec 07 05:26 PM
ADVENT INTERNATIONAL CORP/MA	10% Owner	Dec 03	Sale	61.28	3,228,241	197,826,608	15,418,795	Dec 07 05:25 PM
ADVENT INTERNATIONAL CORP/MA	10% Owner	Dec 03	Sale	61.28	3,228,241	197,826,608	15,418,795	Dec 07 05:22 PM
Maldonado John L.	Director	Dec 03	Sale	61.28	3,228,241	197,826,608	15,418,795	Dec 07 05:18 PM
ADVENT INTERNATIONAL CORP/MA	10% Owner	Dec 03	Sale	61.28	3,228,241	197,826,608	15,418,795	Dec 07 05:13 PM
THOMAS H. LEE ADVISORS, LLC	Director	Dec 03	Sale	61.28	2,771,132	169,814,969	13,235,545	Dec 07 05:09 PM
THOMAS H. LEE ADVISORS, LLC	Director	Dec 03	Sale	61.28	627	38,423	831	Dec 07 05:09 PM
ADVENT INTERNATIONAL CORP/MA	10% Owner	Dec 03	Sale	61.28	3,228,241	197,826,608	15,418,795	Dec 07 05:07 PM
THOMAS H. LEE ADVISORS, LLC	Director	Dec 03	Sale	61.28	2,771,132	169,814,969	13,235,545	Dec 07 05:05 PM
THOMAS H. LEE ADVISORS, LLC	Director	Dec 03	Sale	61.28	627	38,423	831	Dec 07 05:05 PM
ADVENT INTERNATIONAL CORP/MA	10% Owner	Dec 03	Sale	61.28	3,228,241	197,826,608	15,418,795	Dec 07 04:53 PM
Meggs Jason M.	Chief Financial Officer	Nov 27	Sale	67.00	4,062	272,154	66,003	Nov 30 05:12 PM
Meggs Jason M.	Chief Financial Officer	Nov 24	Sale	67.00	1,938	129,846	70,065	Nov 25 05:01 PM
KEEFE MICHELLE	Pres., Commercial Solutions	Nov 18	Sale	65.00	856	55,640	48,881	Nov 19 05:00 PM
KEEFE MICHELLE	Pres., Commercial Solutions	Nov 17	Sale	62.65	800	50,120	49,643	Nov 19 05:00 PM
ADVENT INTERNATIONAL CORP/MA	10% Owner	Sep 17	Sale	59.26	3,766,281	223,189,812	18,647,036	Sep 21 09:56 PM
ADVENT INTERNATIONAL CORP/MA	10% Owner	Sep 17	Sale	59.26	3,766,281	223,189,812	18,647,036	Sep 21 09:56 PM
ADVENT INTERNATIONAL CORP/MA	10% Owner	Sep 17	Sale	59.26	3,766,281	223,189,812	18,647,036	Sep 21 09:55 PM
Allen Tom	Director	Sep 17	Sale	59.26	3,766,281	223,189,812	18,647,036	Sep 21 09:55 PM
ADVENT INTERNATIONAL CORP/MA	10% Owner	Sep 17	Sale	59.26	3,766,281	223,189,812	18,647,036	Sep 21 09:55 PM
Maldonado John L.	Director	Sep 17	Sale	59.26	3,766,281	223,189,812	18,647,036	Sep 21 09:54 PM
ADVENT INTERNATIONAL CORP/MA	10% Owner	Sep 17	Sale	59.26	3,766,281	223,189,812	18,647,036	Sep 21 09:54 PM
ADVENT INTERNATIONAL CORP/MA	10% Owner	Sep 17	Sale	59.26	3,766,281	223,189,812	18,647,036	Sep 21 09:53 PM
THOMAS H. LEE ADVISORS, LLC	Director	Sep 17	Sale	59.26	3,232,987	191,586,810	16,006,677	Sep 21 05:39 PM
THOMAS H. LEE ADVISORS, LLC	Director	Sep 17	Sale	59.26	732	43,378	1,005	Sep 21 05:39 PM
THOMAS H. LEE ADVISORS, LLC	Director	Sep 17	Sale	59.26	3,232,987	191,586,810	16,006,677	Sep 21 05:30 PM
THOMAS H. LEE ADVISORS, LLC	Director	Sep 17	Sale	59.26	732	43,378	1,005	Sep 21 05:30 PM
Macdonald Alistair	Chief Executive Officer	Aug 03	Sale	65.07	10,289	669,464	246,687	Aug 04 05:06 PM
Macdonald Alistair	Chief Executive Officer	Jul 15	Option Exercise	16.06	37,868	608,160	280,088	Jul 17 05:03 PM
Macdonald Alistair	Chief Executive Officer	Jul 15	Sale	60.14	37,868	2,277,495	261,154	Jul 17 05:03 PM
Macdonald Alistair	Chief Executive Officer	Jul 14	Option Exercise	10.57	5,173	54,679	266,327	Jul 15 05:03 PM
Macdonald Alistair	Chief Executive Officer	Jul 14	Sale	58.68	5,173	303,553	261,154	Jul 15 05:03 PM
Macdonald Alistair	Chief Executive Officer	Jul 13	Option Exercise	10.57	3,655	38,633	264,809	Jul 15 05:03 PM
Macdonald Alistair	Chief Executive Officer	Jul 13	Sale	58.21	3,655	212,747	261,154	Jul 15 05:03 PM
Dineen John M.	Director	Jul 06	Buy	59.11	8,691	513,725	17,426	Jul 08 05:04 PM
KEEFE MICHELLE	Pres., Commercial Solutions	Jul 06	Sale	59.11	1,500	88,665	50,443	Jul 08 05:06 PM
KEEFE MICHELLE	Pres., Commercial Solutions	May 20	Sale	60.00	2,500	150,000	51,943	May 21 05:01 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience